Skip to content

Clinical trials

Carcinoma, Medullary trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Status: Unknown status Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20132
20141
20181
20213
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique Hopitaux De Marseille1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
First Affiliated Hospital of Fujian Medical University1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Instituto Nacional de Cancer, Brazil1
Leiden University Medical Center1
Salient Pharmaceuticals Incorporated1
Shouyao Holdings (Beijing) Co. LTD1
TYK Medicines, Inc1
The Leeds Teaching Hospitals NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary13
Thyroid Cancer, Papillary3
Thyroid Carcinoma, Anaplastic3
Thyroid Neoplasms3
Adenocarcinoma, Follicular2
Alzheimer Disease1
Carcinoid Tumor1
Carcinoma, Non-Small-Cell Lung1
Dementia1
Diarrhea1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.